Healthcare -
Biotechnology - NASDAQ - US
$ 20.285
-1.96 %
$ 15 B
Market Cap
-65.44
P/E
SMMT - OTHER CURRENT LIABILITIES
Other Current Liabilities SMMT - Summit Therapeutics Inc.
14.9 M
LAST VALUE
9.27%
2 YEAR CAGR
6.63%
5 YEAR CAGR
19.98%
10 YEAR CAGR